Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.44%
)
US TECH 100
23,527.60
(
0.55%
)
Dow Jones
46,669.88
(
0.36%
)
Brent Oil
106.89
(
-2.09%
)
Bitcoin
69,870.16
(
1.25%
)
News Focus
News Focus
Post# of 7247
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122852
Boards Moderated 8
Alias Born 09/05/2002

DewDiligence

Member Level

Re: deet49 post# 149

Friday, 08/20/2010 7:26:21 PM

Friday, August 20, 2010 7:26:21 PM

Post# of 7247
I’m well aware of the Bapineuzumab program and the respective economic shares of the program owned by PFE, JNJ, and ELN. The biomedreports.com blurb you posted in #msg-53531204 is spam under the guise of being news, which is par for the course for that rag.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PFE News
More PFE News